ADCY5 and type 2 diabetes mellitus: Importantly, we demonstrate that disruption of each, the regulator SREBP1, the variant rs56371916, and the target gene ADCY5 cause cellular changes (e.g., lipid oxidation) relevant to BMD and T2D.